Targeting HMGA1 contributes to immunotherapy in aggressive breast cancer while suppressing EMT

Cancer statistics, 2022

Rebecca L. Siegel, Kimberly D. Miller, Hannah E. Fuchs et al. · CA A Cancer Journal for Clinicians · 2022 · 17.9K citations · Full text

Epidemiology Of Cancer, Population Health Sciences, Cancer Registration +18

Triple-Negative Breast Cancer: Clinical Features and Patterns of Recurrence

Rebecca Dent, Maureen Trudeau, Kathleen I. Pritchard et al. · Clinical Cancer Research · 2007 · 5K citations · Full text

PD‐L1 promotes OCT4 and Nanog expression in breast cancer stem cells by sustaining PI3K/AKT pathway activation

Sheema Almozyan, Dilek Çolak, Fatmah A. Mansour et al. · International Journal of Cancer · 2017 · 252 citations · Full text

The immune checkpoint ligand PD-L1 is upregulated in EMT-activated human breast cancer cells by a mechanism involving ZEB-1 and miR-200

Muhammad Zaeem Noman, Bassam Janji, Abdérémane Abdou et al. · OncoImmunology · 2017 · 244 citations · Full text

Architectural Transcription Factor HMGI(Y) Promotes Tumor Progression and Mesenchymal Transition of Human Epithelial Cells

Raymond Reeves, Dale D. Edberg, Ying Li · Molecular and Cellular Biology · 2001 · 237 citations · Full text

Tumor Progression, Cancer Biology, Tumor Biology +18